Tilt Investment Management Holdings PBC Sells 904 Shares of Danaher Co. (NYSE:DHR)

Tilt Investment Management Holdings PBC cut its holdings in shares of Danaher Co. (NYSE:DHR) by 25.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,619 shares of the conglomerate’s stock after selling 904 shares during the period. Tilt Investment Management Holdings PBC’s holdings in Danaher were worth $607,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Fairfield Bush & CO. raised its stake in shares of Danaher by 10.9% in the first quarter. Fairfield Bush & CO. now owns 4,840 shares of the conglomerate’s stock worth $1,420,000 after purchasing an additional 475 shares during the last quarter. Zions Bancorporation N.A. raised its position in Danaher by 19.3% in the 1st quarter. Zions Bancorporation N.A. now owns 2,468 shares of the conglomerate’s stock valued at $724,000 after buying an additional 400 shares during the last quarter. Covestor Ltd lifted its stake in Danaher by 76.8% during the 1st quarter. Covestor Ltd now owns 495 shares of the conglomerate’s stock valued at $145,000 after acquiring an additional 215 shares in the last quarter. NewEdge Advisors LLC boosted its holdings in Danaher by 14.1% during the 1st quarter. NewEdge Advisors LLC now owns 31,530 shares of the conglomerate’s stock worth $9,248,000 after acquiring an additional 3,897 shares during the last quarter. Finally, Bridgewater Associates LP grew its stake in shares of Danaher by 135.9% in the 1st quarter. Bridgewater Associates LP now owns 35,270 shares of the conglomerate’s stock worth $10,346,000 after acquiring an additional 20,320 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, SVP Daniel Raskas sold 23,757 shares of the stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now owns 38,102 shares of the company’s stock, valued at $9,601,704. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Danaher news, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the transaction, the senior vice president now directly owns 38,102 shares of the company’s stock, valued at $9,601,704. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Georgeann Couchara sold 2,622 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total transaction of $636,280.74. Following the completion of the sale, the senior vice president now owns 4,244 shares of the company’s stock, valued at $1,029,891.48. The disclosure for this sale can be found here. Insiders sold a total of 32,957 shares of company stock worth $8,265,802 over the last ninety days. 11.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on DHR shares. Barclays boosted their price target on shares of Danaher from $240.00 to $260.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 10th. KeyCorp lifted their price target on Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Royal Bank of Canada upped their price objective on Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Finally, JPMorgan Chase & Co. increased their price target on shares of Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research report on Wednesday, December 20th. Six equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $268.27.

Danaher Stock Performance

DHR stock traded down $3.60 during midday trading on Thursday, reaching $235.79. 2,790,267 shares of the company’s stock traded hands, compared to its average volume of 2,708,023. The firm has a market capitalization of $174.61 billion, a PE ratio of 37.46, a price-to-earnings-growth ratio of 3.65 and a beta of 0.83. The company has a 50-day moving average price of $249.28 and a two-hundred day moving average price of $229.86. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $259.00. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.37 and a current ratio of 1.68.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.91 by $0.18. The company had revenue of $6.41 billion for the quarter, compared to analyst estimates of $6.10 billion. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The firm’s revenue for the quarter was down 10.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.87 EPS. As a group, equities analysts anticipate that Danaher Co. will post 7.62 EPS for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Thursday, March 28th will be given a $0.27 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date is Wednesday, March 27th. Danaher’s dividend payout ratio (DPR) is 16.90%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.